Conduction Disorders after Surgical Aortic Valve Replacement Using a Rapid Deployment Aortic Valve Prosthesis: Medium-Term Follow-Up.

conduction disorders left bundle branch block (LBBB) rapid deployment aortic valve prosthesis

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
06 Mar 2023
Historique:
received: 05 01 2023
revised: 25 02 2023
accepted: 28 02 2023
entrez: 11 3 2023
pubmed: 12 3 2023
medline: 12 3 2023
Statut: epublish

Résumé

We have previously reported that the incidence of postoperative conduction disorders, especially left bundle branch block (LBBB), after implantation of a rapid deployment Intuity™ Elite aortic valve prosthesis (Edwards Lifesciences, Irvine, CA, USA), was significantly increased compared with conventional aortic valve replacement. We were now interested in how these disorders behaved at intermediate follow-up. All 87 patients who had undergone surgical aortic valve replacement (SAVR) using the rapid deployment Intuity™ Elite prosthesis and were shown to have conduction disorders at the time of hospital discharge were followed up after surgery. These patients' ECGs were recorded at least 1 year after surgery, and the persistence of the new postoperative conduction disorders was assessed. At hospital discharge, 48.1% of the patients had developed new postoperative conduction disorders, with LBBB being the predominant conduction disturbance (36.5%). At medium-term follow-up (526 days, standard deviation (SD) = 169.6, standard error (SE) = 19.3 days, respectively), 44% of the new LBBB and 50% of the new right bundle branch block (RBBB) had disappeared. There was no new atrio-ventricular block III (AVB III) that occurred. One new pacemaker (PM) was implanted during follow-up because of AVB II Mobitz type II. At medium-term follow-up after the implantation of a rapid deployment Intuity™ Elite aortic valve prosthesis, the number of new postoperative conduction disorders, especially LBBB, has considerably decreased but remains high. The incidence of postoperative AV block III remained stable.

Sections du résumé

BACKGROUND BACKGROUND
We have previously reported that the incidence of postoperative conduction disorders, especially left bundle branch block (LBBB), after implantation of a rapid deployment Intuity™ Elite aortic valve prosthesis (Edwards Lifesciences, Irvine, CA, USA), was significantly increased compared with conventional aortic valve replacement. We were now interested in how these disorders behaved at intermediate follow-up.
METHODS METHODS
All 87 patients who had undergone surgical aortic valve replacement (SAVR) using the rapid deployment Intuity™ Elite prosthesis and were shown to have conduction disorders at the time of hospital discharge were followed up after surgery. These patients' ECGs were recorded at least 1 year after surgery, and the persistence of the new postoperative conduction disorders was assessed.
RESULTS RESULTS
At hospital discharge, 48.1% of the patients had developed new postoperative conduction disorders, with LBBB being the predominant conduction disturbance (36.5%). At medium-term follow-up (526 days, standard deviation (SD) = 169.6, standard error (SE) = 19.3 days, respectively), 44% of the new LBBB and 50% of the new right bundle branch block (RBBB) had disappeared. There was no new atrio-ventricular block III (AVB III) that occurred. One new pacemaker (PM) was implanted during follow-up because of AVB II Mobitz type II.
CONCLUSIONS CONCLUSIONS
At medium-term follow-up after the implantation of a rapid deployment Intuity™ Elite aortic valve prosthesis, the number of new postoperative conduction disorders, especially LBBB, has considerably decreased but remains high. The incidence of postoperative AV block III remained stable.

Identifiants

pubmed: 36902870
pii: jcm12052083
doi: 10.3390/jcm12052083
pmc: PMC10004204
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Circulation. 2012 Aug 7;126(6):720-8
pubmed: 22791865
J Thorac Cardiovasc Surg. 1982 Sep;84(3):382-6
pubmed: 7109669
J Thorac Cardiovasc Surg. 2013 Jan;145(1):110-5; discussion 115-6
pubmed: 23058665
JACC Cardiovasc Interv. 2012 May;5(5):540-551
pubmed: 22625193
J Am Coll Cardiol. 2012 Oct 30;60(18):1743-52
pubmed: 23040577
Semin Thorac Cardiovasc Surg. 2018 Spring;30(1):16-23
pubmed: 29031706
Arch Cardiovasc Dis. 2017 Dec;110(12):667-675
pubmed: 28964778
Innovations (Phila). 2018 May/Jun;13(3):177-183
pubmed: 29912142
J Thorac Dis. 2019 Jul;11(7):2945-2954
pubmed: 31463124
JACC Cardiovasc Interv. 2014 Feb;7(2):128-136
pubmed: 24440024
Ann Thorac Surg. 2018 Aug;106(2):460-465
pubmed: 29577930
J Card Surg. 2017 Jun;32(6):322-327
pubmed: 28493342
Am Heart J. 2010 Mar;159(3):497-503
pubmed: 20211315
Am J Cardiol. 2004 Oct 15;94(8):1008-11
pubmed: 15476613
J Cardiovasc Med (Hagerstown). 2010 Jan;11(1):14-9
pubmed: 19829137
Rev Esp Cardiol. 2010 Dec;63(12):1444-51
pubmed: 21144405
Innovations (Phila). 2018 Sep/Oct;13(5):356-360
pubmed: 30394957
J Thorac Dis. 2017 Mar;9(3):711-724
pubmed: 28449479
JACC Cardiovasc Interv. 2008 Jun;1(3):310-6
pubmed: 19463319
Interact Cardiovasc Thorac Surg. 2019 Apr 1;28(4):581-586
pubmed: 30412244
J Thorac Cardiovasc Surg. 2017 Nov;154(5):1556-1565.e1
pubmed: 28712585
Ann Thorac Surg. 2017 Oct;104(4):1259-1264
pubmed: 28433222
Eur J Cardiothorac Surg. 2019 Jun 1;55(6):1168-1173
pubmed: 30561575
Eur J Cardiothorac Surg. 2020 Aug 1;58(2):335-342
pubmed: 32215660
J Geriatr Cardiol. 2018 Jan;15(1):105-112
pubmed: 29434632

Auteurs

Christian Mogilansky (C)

Department of Cardiac Surgery, Klinikum Passau, 94032 Passau, Germany.

Parwis Massoudy (P)

Department of Cardiac Surgery, Klinikum Passau, 94032 Passau, Germany.

Markus Czesla (M)

Department of Cardiac Surgery, Klinikum Passau, 94032 Passau, Germany.

Robert Balan (R)

Department of Cardiac Surgery, Klinikum Passau, 94032 Passau, Germany.

Classifications MeSH